Short Interest in Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) Rises By 309.1%

Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) saw a large increase in short interest in April. As of April 15th, there was short interest totalling 22,500 shares, an increase of 309.1% from the March 31st total of 5,500 shares. Based on an average daily trading volume, of 27,900 shares, the days-to-cover ratio is presently 0.8 days.

Scinai Immunotherapeutics Stock Down 4.7 %

Shares of Scinai Immunotherapeutics stock traded down $0.02 on Thursday, hitting $0.45. 5,585 shares of the company traded hands, compared to its average volume of 26,550. The company has a market cap of $841,500.00, a PE ratio of -0.14 and a beta of 2.50. The company has a 50-day moving average price of $0.49 and a 200 day moving average price of $0.58. Scinai Immunotherapeutics has a 12-month low of $0.43 and a 12-month high of $2.27.

About Scinai Immunotherapeutics

Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications.